These novel drugs , including copyright , Mounjaro , and Zaxig , represent a major advancement in managing type 2 hyperglycemia and promoting weight loss . They work by emulating the body’s natural incretin signal , helping to control blood glucose and reduce appetite . Each therapy has somewhat distinct qualities and may be suitable for diverse